Slendesta, a potato extract ingredient for weight management, has been given non-Novel Food approval by Canada.
Slendesta, a potato extract ingredient for weight management, has been given non-Novel Food approval by Canada. By no longer being considered a Novel Food, Slendesta may be used in conventional food and beverages at specified inclusion levels, without requiring premarket notification.
“Our customers in Canada will now be able to get to market faster since they don’t need to go through a premarket notification process,” says Linda Fullmer, Kemin’s senior vice presidient of marketing.
Slendesta is produced by Kemin Health LC (Des Moines, IA). The ingredient’s active component, Proteinase Inhibitor II (P12), is derived from U.S.-grown white potatoes and enhances the body’s natural release of cholecystokinin (CCK). CCK is a signaling peptide that, once released, helps induce feelings of satiety.
Slendesta is also not considered a novel food in Europe and has GRAS status in the United States.